Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | ENPP3 | O14638 | 3/20 | 0.39 |
| ▸ | ALPL | P05186 | 3/20 | 0.39 |
| ▸ | XIAP | P98170 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23564670 | 0.82 | TSHR (0.39) | POLBHSD17B10ENPP3ALPLXIAP | |
| SCHEMBL23564635 | 0.74 | ENPP3 (0.47) | POLBHSD17B10ENPP3ALPLXIAP | |
| SCHEMBL23564547 | 0.74 | ALDH1A1 (0.43) | ENPP3ALPLXIAPALDH1A1GAA | |
| SCHEMBL23564551 | 0.71 | TSHR (0.42) | POLBHSD17B10ENPP3ALPLXIAP | |
| SCHEMBL19150297 | 0.70 | ALDH1A1 (0.46) | POLBHSD17B10ENPP3ALPLXIAP | |
| SCHEMBL4436614 | 0.69 | TSHR (0.47) | POLBENPP3ALPLXIAPALDH1A1 | |
| SCHEMBL23564556 | 0.69 | TSHR (0.45) | POLBHSD17B10ENPP3ALPLXIAP | |
| SCHEMBL13305863 | 0.67 | ALDH1A1 (0.47) | HSD17B10ALDH1A1L3MBTL1ALOX15 | |
| SCHEMBL4436617 | 0.67 | TSHR (0.44) | POLBENPP3ALPLXIAPALDH1A1 | |
| SCHEMBL23564554 | 0.66 | ALDH1A1 (0.43) | POLBHSD17B10ENPP3ALPLXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11820838-B2 | Modified diene-based polymer | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-11-21 | — | — | US | disclosed |
| US-11820838-B2 | Modified diene-based polymer | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-11-21 | — | — | US | disclosed |
| US-11787879-B2 | Production method of modified diene-based polymer | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-10-17 | — | — | US | disclosed |
| US-11787879-B2 | Production method of modified diene-based polymer | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-10-17 | — | — | US | disclosed |
| US-11370760-B2 | Dithioester compound | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20210188780-A1 | DITHIOESTER COMPOUND | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2021-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370760-B2 | Dithioester compound | SQOR, LANCL1, AKR1C4 | POLB 4586/4885HSD17B10 105/4885ENPP3 1752/4885 |
| US-20210188780-A1 | DITHIOESTER COMPOUND | SQOR, LANCL1, AKR1C4 | POLB 4654/4885HSD17B10 104/4885ENPP3 1561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.